Marburg, Ebola Sudan Vaccines Might Get Share of COVAX Surplus 04/07/2023 Megha Kaveri Some of the $2.6 billion that remains in a COVID-19 vaccine delivery scheme, COVAX, could be redirected into investment into investigational vaccine candidates for Marburg Virus Disease (MVD) and Ebola Sudan strain virus, as well as over half a dozen other vaccine programmes that were suspended due to the pandemic or delays in product development, […] Continue reading -> WHO Launches New Guideline for Protecting Children from Unhealthy Food Marketing 03/07/2023 Stefan Anderson The World Health Organization (WHO) launched a new guideline on Monday in a bid to push governments to adopt more stringent regulations on the marketing of unhealthy foods high in saturated fatty acids, trans-fatty acids, free sugars or salt (HFSS) to children. The UN health body has hardened its stance on what it describes as […] Continue reading -> Attacks on LGBTQ Ugandans Increase as World Bank Under Pressure to Suspend Lending 01/07/2023 Kerry Cullinan As Pride month celebrations wind down in parts of the world that recognise LGBTQ rights, Ugandan human rights organisations have recorded a record number of abuses against that community following the introduction of the Anti-Homosexuality Act in that country one month ago. Meanwhile, the World Bank sent a fact-finding mission to Uganda last week following […] Continue reading -> India Introduces ‘Green Credit’ Scheme to Drive Clean Development – But Feasibility of Plan Unclear 30/06/2023 Jyoti Pande Lavakare India this week published the draft of a Green Credit Programme aimed at incentivising environmentally conscious practices to promote a sustainable lifestyle as part of the broader Indian initiative, Lifestyle for Environment (LiFE). The new Green Credit Programme aims to lay the foundation for a market-based mechanism to promote “a grassroot mass movement for combating […] Continue reading -> Haitian Gangs Use Rape as Weapon of Terror – And There is Little Support for Survivors 30/06/2023 André Paultre & Daniela Mohor PORT-AU-PRINCE – In Haiti, rape has become a weapon of war for gangs. What happens in the hours and days after women and girls are raped can determine their future, but most survivors face insurmountable obstacles before they can start recovering physically and mentally. And that’s if they aren’t raped a second time or third […] Continue reading -> ‘Impossible to Have Healthy People on a Sick Planet’: Fighting Back Against Air Pollution 30/06/2023 Maayan Hoffman The World Health Organization (WHO) estimates that some 99% of the world’s population lives where the WHO air quality guidelines are not met. Air pollution poses one of the most significant environmental risks to health in the modern world, and in the latest episode of the “Global Health Matters” podcast, host Garry Aslanyan speaks with […] Continue reading -> TB Vaccine Candidate Receives $550M Boost for Phase 3 Trial 29/06/2023 Megha Kaveri A tuberculosis (TB) vaccine candidate that has shown modest efficacy rates received a $550 million boost from the Bill and Melinda Gates Foundation (BMGF) and Wellcome Trust, which announced on Tuesday that they will cover its Phase 3 clinical trials. The candidate vaccine, M72, showed modest 54% efficacy in preventing the development of symptomatic TB […] Continue reading -> Virus ‘Superspreaders’: No Link to Severity of COVID-19 Symptoms 28/06/2023 Stefan Anderson Since the beginning of the SARS-CoV-2 pandemic, the popular assumption was that people displaying severe symptons were also the most contagious. But new data from a controversial Imperial College London study published on Tuesday found the two participants that were the biggest “superspreaders” of the virus both displayed only minor symptoms. “How symptomatic a person […] Continue reading -> The Gambia Mandates Pre-shipment Quality Testing for All Medicines Exported from India 28/06/2023 Megha Kaveri The Gambia has mandated pre-shipment quality testing on all pharmaceutical products exported from India. The requirement will come into effect on 1 July 2023. It can be understood as an after-effect of last year’s scandal whereby India-manufactured cough syrups allegedly claimed the lives of 66 children in The Gambia in 2022 . Following the episode, […] Continue reading -> Medicines Patent Pool Announces Licenses for Generic COVID-19 Antiviral 27/06/2023 Stefan Anderson The Medicines Patent Pool (MPP) announced sublicensing agreements with seven manufacturers to produce and distribute generic versions of Japanese pharmaceutical company Shinogi’s COVID-19 antiviral treatment in 117 low- and middle-income countries. Ensitrelvir is an oral antiviral currently only approved in Japan under the country’s emergency regulatory approval system. The drug is being evaluated under a […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Launches New Guideline for Protecting Children from Unhealthy Food Marketing 03/07/2023 Stefan Anderson The World Health Organization (WHO) launched a new guideline on Monday in a bid to push governments to adopt more stringent regulations on the marketing of unhealthy foods high in saturated fatty acids, trans-fatty acids, free sugars or salt (HFSS) to children. The UN health body has hardened its stance on what it describes as […] Continue reading -> Attacks on LGBTQ Ugandans Increase as World Bank Under Pressure to Suspend Lending 01/07/2023 Kerry Cullinan As Pride month celebrations wind down in parts of the world that recognise LGBTQ rights, Ugandan human rights organisations have recorded a record number of abuses against that community following the introduction of the Anti-Homosexuality Act in that country one month ago. Meanwhile, the World Bank sent a fact-finding mission to Uganda last week following […] Continue reading -> India Introduces ‘Green Credit’ Scheme to Drive Clean Development – But Feasibility of Plan Unclear 30/06/2023 Jyoti Pande Lavakare India this week published the draft of a Green Credit Programme aimed at incentivising environmentally conscious practices to promote a sustainable lifestyle as part of the broader Indian initiative, Lifestyle for Environment (LiFE). The new Green Credit Programme aims to lay the foundation for a market-based mechanism to promote “a grassroot mass movement for combating […] Continue reading -> Haitian Gangs Use Rape as Weapon of Terror – And There is Little Support for Survivors 30/06/2023 André Paultre & Daniela Mohor PORT-AU-PRINCE – In Haiti, rape has become a weapon of war for gangs. What happens in the hours and days after women and girls are raped can determine their future, but most survivors face insurmountable obstacles before they can start recovering physically and mentally. And that’s if they aren’t raped a second time or third […] Continue reading -> ‘Impossible to Have Healthy People on a Sick Planet’: Fighting Back Against Air Pollution 30/06/2023 Maayan Hoffman The World Health Organization (WHO) estimates that some 99% of the world’s population lives where the WHO air quality guidelines are not met. Air pollution poses one of the most significant environmental risks to health in the modern world, and in the latest episode of the “Global Health Matters” podcast, host Garry Aslanyan speaks with […] Continue reading -> TB Vaccine Candidate Receives $550M Boost for Phase 3 Trial 29/06/2023 Megha Kaveri A tuberculosis (TB) vaccine candidate that has shown modest efficacy rates received a $550 million boost from the Bill and Melinda Gates Foundation (BMGF) and Wellcome Trust, which announced on Tuesday that they will cover its Phase 3 clinical trials. The candidate vaccine, M72, showed modest 54% efficacy in preventing the development of symptomatic TB […] Continue reading -> Virus ‘Superspreaders’: No Link to Severity of COVID-19 Symptoms 28/06/2023 Stefan Anderson Since the beginning of the SARS-CoV-2 pandemic, the popular assumption was that people displaying severe symptons were also the most contagious. But new data from a controversial Imperial College London study published on Tuesday found the two participants that were the biggest “superspreaders” of the virus both displayed only minor symptoms. “How symptomatic a person […] Continue reading -> The Gambia Mandates Pre-shipment Quality Testing for All Medicines Exported from India 28/06/2023 Megha Kaveri The Gambia has mandated pre-shipment quality testing on all pharmaceutical products exported from India. The requirement will come into effect on 1 July 2023. It can be understood as an after-effect of last year’s scandal whereby India-manufactured cough syrups allegedly claimed the lives of 66 children in The Gambia in 2022 . Following the episode, […] Continue reading -> Medicines Patent Pool Announces Licenses for Generic COVID-19 Antiviral 27/06/2023 Stefan Anderson The Medicines Patent Pool (MPP) announced sublicensing agreements with seven manufacturers to produce and distribute generic versions of Japanese pharmaceutical company Shinogi’s COVID-19 antiviral treatment in 117 low- and middle-income countries. Ensitrelvir is an oral antiviral currently only approved in Japan under the country’s emergency regulatory approval system. The drug is being evaluated under a […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Attacks on LGBTQ Ugandans Increase as World Bank Under Pressure to Suspend Lending 01/07/2023 Kerry Cullinan As Pride month celebrations wind down in parts of the world that recognise LGBTQ rights, Ugandan human rights organisations have recorded a record number of abuses against that community following the introduction of the Anti-Homosexuality Act in that country one month ago. Meanwhile, the World Bank sent a fact-finding mission to Uganda last week following […] Continue reading -> India Introduces ‘Green Credit’ Scheme to Drive Clean Development – But Feasibility of Plan Unclear 30/06/2023 Jyoti Pande Lavakare India this week published the draft of a Green Credit Programme aimed at incentivising environmentally conscious practices to promote a sustainable lifestyle as part of the broader Indian initiative, Lifestyle for Environment (LiFE). The new Green Credit Programme aims to lay the foundation for a market-based mechanism to promote “a grassroot mass movement for combating […] Continue reading -> Haitian Gangs Use Rape as Weapon of Terror – And There is Little Support for Survivors 30/06/2023 André Paultre & Daniela Mohor PORT-AU-PRINCE – In Haiti, rape has become a weapon of war for gangs. What happens in the hours and days after women and girls are raped can determine their future, but most survivors face insurmountable obstacles before they can start recovering physically and mentally. And that’s if they aren’t raped a second time or third […] Continue reading -> ‘Impossible to Have Healthy People on a Sick Planet’: Fighting Back Against Air Pollution 30/06/2023 Maayan Hoffman The World Health Organization (WHO) estimates that some 99% of the world’s population lives where the WHO air quality guidelines are not met. Air pollution poses one of the most significant environmental risks to health in the modern world, and in the latest episode of the “Global Health Matters” podcast, host Garry Aslanyan speaks with […] Continue reading -> TB Vaccine Candidate Receives $550M Boost for Phase 3 Trial 29/06/2023 Megha Kaveri A tuberculosis (TB) vaccine candidate that has shown modest efficacy rates received a $550 million boost from the Bill and Melinda Gates Foundation (BMGF) and Wellcome Trust, which announced on Tuesday that they will cover its Phase 3 clinical trials. The candidate vaccine, M72, showed modest 54% efficacy in preventing the development of symptomatic TB […] Continue reading -> Virus ‘Superspreaders’: No Link to Severity of COVID-19 Symptoms 28/06/2023 Stefan Anderson Since the beginning of the SARS-CoV-2 pandemic, the popular assumption was that people displaying severe symptons were also the most contagious. But new data from a controversial Imperial College London study published on Tuesday found the two participants that were the biggest “superspreaders” of the virus both displayed only minor symptoms. “How symptomatic a person […] Continue reading -> The Gambia Mandates Pre-shipment Quality Testing for All Medicines Exported from India 28/06/2023 Megha Kaveri The Gambia has mandated pre-shipment quality testing on all pharmaceutical products exported from India. The requirement will come into effect on 1 July 2023. It can be understood as an after-effect of last year’s scandal whereby India-manufactured cough syrups allegedly claimed the lives of 66 children in The Gambia in 2022 . Following the episode, […] Continue reading -> Medicines Patent Pool Announces Licenses for Generic COVID-19 Antiviral 27/06/2023 Stefan Anderson The Medicines Patent Pool (MPP) announced sublicensing agreements with seven manufacturers to produce and distribute generic versions of Japanese pharmaceutical company Shinogi’s COVID-19 antiviral treatment in 117 low- and middle-income countries. Ensitrelvir is an oral antiviral currently only approved in Japan under the country’s emergency regulatory approval system. The drug is being evaluated under a […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
India Introduces ‘Green Credit’ Scheme to Drive Clean Development – But Feasibility of Plan Unclear 30/06/2023 Jyoti Pande Lavakare India this week published the draft of a Green Credit Programme aimed at incentivising environmentally conscious practices to promote a sustainable lifestyle as part of the broader Indian initiative, Lifestyle for Environment (LiFE). The new Green Credit Programme aims to lay the foundation for a market-based mechanism to promote “a grassroot mass movement for combating […] Continue reading -> Haitian Gangs Use Rape as Weapon of Terror – And There is Little Support for Survivors 30/06/2023 André Paultre & Daniela Mohor PORT-AU-PRINCE – In Haiti, rape has become a weapon of war for gangs. What happens in the hours and days after women and girls are raped can determine their future, but most survivors face insurmountable obstacles before they can start recovering physically and mentally. And that’s if they aren’t raped a second time or third […] Continue reading -> ‘Impossible to Have Healthy People on a Sick Planet’: Fighting Back Against Air Pollution 30/06/2023 Maayan Hoffman The World Health Organization (WHO) estimates that some 99% of the world’s population lives where the WHO air quality guidelines are not met. Air pollution poses one of the most significant environmental risks to health in the modern world, and in the latest episode of the “Global Health Matters” podcast, host Garry Aslanyan speaks with […] Continue reading -> TB Vaccine Candidate Receives $550M Boost for Phase 3 Trial 29/06/2023 Megha Kaveri A tuberculosis (TB) vaccine candidate that has shown modest efficacy rates received a $550 million boost from the Bill and Melinda Gates Foundation (BMGF) and Wellcome Trust, which announced on Tuesday that they will cover its Phase 3 clinical trials. The candidate vaccine, M72, showed modest 54% efficacy in preventing the development of symptomatic TB […] Continue reading -> Virus ‘Superspreaders’: No Link to Severity of COVID-19 Symptoms 28/06/2023 Stefan Anderson Since the beginning of the SARS-CoV-2 pandemic, the popular assumption was that people displaying severe symptons were also the most contagious. But new data from a controversial Imperial College London study published on Tuesday found the two participants that were the biggest “superspreaders” of the virus both displayed only minor symptoms. “How symptomatic a person […] Continue reading -> The Gambia Mandates Pre-shipment Quality Testing for All Medicines Exported from India 28/06/2023 Megha Kaveri The Gambia has mandated pre-shipment quality testing on all pharmaceutical products exported from India. The requirement will come into effect on 1 July 2023. It can be understood as an after-effect of last year’s scandal whereby India-manufactured cough syrups allegedly claimed the lives of 66 children in The Gambia in 2022 . Following the episode, […] Continue reading -> Medicines Patent Pool Announces Licenses for Generic COVID-19 Antiviral 27/06/2023 Stefan Anderson The Medicines Patent Pool (MPP) announced sublicensing agreements with seven manufacturers to produce and distribute generic versions of Japanese pharmaceutical company Shinogi’s COVID-19 antiviral treatment in 117 low- and middle-income countries. Ensitrelvir is an oral antiviral currently only approved in Japan under the country’s emergency regulatory approval system. The drug is being evaluated under a […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Haitian Gangs Use Rape as Weapon of Terror – And There is Little Support for Survivors 30/06/2023 André Paultre & Daniela Mohor PORT-AU-PRINCE – In Haiti, rape has become a weapon of war for gangs. What happens in the hours and days after women and girls are raped can determine their future, but most survivors face insurmountable obstacles before they can start recovering physically and mentally. And that’s if they aren’t raped a second time or third […] Continue reading -> ‘Impossible to Have Healthy People on a Sick Planet’: Fighting Back Against Air Pollution 30/06/2023 Maayan Hoffman The World Health Organization (WHO) estimates that some 99% of the world’s population lives where the WHO air quality guidelines are not met. Air pollution poses one of the most significant environmental risks to health in the modern world, and in the latest episode of the “Global Health Matters” podcast, host Garry Aslanyan speaks with […] Continue reading -> TB Vaccine Candidate Receives $550M Boost for Phase 3 Trial 29/06/2023 Megha Kaveri A tuberculosis (TB) vaccine candidate that has shown modest efficacy rates received a $550 million boost from the Bill and Melinda Gates Foundation (BMGF) and Wellcome Trust, which announced on Tuesday that they will cover its Phase 3 clinical trials. The candidate vaccine, M72, showed modest 54% efficacy in preventing the development of symptomatic TB […] Continue reading -> Virus ‘Superspreaders’: No Link to Severity of COVID-19 Symptoms 28/06/2023 Stefan Anderson Since the beginning of the SARS-CoV-2 pandemic, the popular assumption was that people displaying severe symptons were also the most contagious. But new data from a controversial Imperial College London study published on Tuesday found the two participants that were the biggest “superspreaders” of the virus both displayed only minor symptoms. “How symptomatic a person […] Continue reading -> The Gambia Mandates Pre-shipment Quality Testing for All Medicines Exported from India 28/06/2023 Megha Kaveri The Gambia has mandated pre-shipment quality testing on all pharmaceutical products exported from India. The requirement will come into effect on 1 July 2023. It can be understood as an after-effect of last year’s scandal whereby India-manufactured cough syrups allegedly claimed the lives of 66 children in The Gambia in 2022 . Following the episode, […] Continue reading -> Medicines Patent Pool Announces Licenses for Generic COVID-19 Antiviral 27/06/2023 Stefan Anderson The Medicines Patent Pool (MPP) announced sublicensing agreements with seven manufacturers to produce and distribute generic versions of Japanese pharmaceutical company Shinogi’s COVID-19 antiviral treatment in 117 low- and middle-income countries. Ensitrelvir is an oral antiviral currently only approved in Japan under the country’s emergency regulatory approval system. The drug is being evaluated under a […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
‘Impossible to Have Healthy People on a Sick Planet’: Fighting Back Against Air Pollution 30/06/2023 Maayan Hoffman The World Health Organization (WHO) estimates that some 99% of the world’s population lives where the WHO air quality guidelines are not met. Air pollution poses one of the most significant environmental risks to health in the modern world, and in the latest episode of the “Global Health Matters” podcast, host Garry Aslanyan speaks with […] Continue reading -> TB Vaccine Candidate Receives $550M Boost for Phase 3 Trial 29/06/2023 Megha Kaveri A tuberculosis (TB) vaccine candidate that has shown modest efficacy rates received a $550 million boost from the Bill and Melinda Gates Foundation (BMGF) and Wellcome Trust, which announced on Tuesday that they will cover its Phase 3 clinical trials. The candidate vaccine, M72, showed modest 54% efficacy in preventing the development of symptomatic TB […] Continue reading -> Virus ‘Superspreaders’: No Link to Severity of COVID-19 Symptoms 28/06/2023 Stefan Anderson Since the beginning of the SARS-CoV-2 pandemic, the popular assumption was that people displaying severe symptons were also the most contagious. But new data from a controversial Imperial College London study published on Tuesday found the two participants that were the biggest “superspreaders” of the virus both displayed only minor symptoms. “How symptomatic a person […] Continue reading -> The Gambia Mandates Pre-shipment Quality Testing for All Medicines Exported from India 28/06/2023 Megha Kaveri The Gambia has mandated pre-shipment quality testing on all pharmaceutical products exported from India. The requirement will come into effect on 1 July 2023. It can be understood as an after-effect of last year’s scandal whereby India-manufactured cough syrups allegedly claimed the lives of 66 children in The Gambia in 2022 . Following the episode, […] Continue reading -> Medicines Patent Pool Announces Licenses for Generic COVID-19 Antiviral 27/06/2023 Stefan Anderson The Medicines Patent Pool (MPP) announced sublicensing agreements with seven manufacturers to produce and distribute generic versions of Japanese pharmaceutical company Shinogi’s COVID-19 antiviral treatment in 117 low- and middle-income countries. Ensitrelvir is an oral antiviral currently only approved in Japan under the country’s emergency regulatory approval system. The drug is being evaluated under a […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
TB Vaccine Candidate Receives $550M Boost for Phase 3 Trial 29/06/2023 Megha Kaveri A tuberculosis (TB) vaccine candidate that has shown modest efficacy rates received a $550 million boost from the Bill and Melinda Gates Foundation (BMGF) and Wellcome Trust, which announced on Tuesday that they will cover its Phase 3 clinical trials. The candidate vaccine, M72, showed modest 54% efficacy in preventing the development of symptomatic TB […] Continue reading -> Virus ‘Superspreaders’: No Link to Severity of COVID-19 Symptoms 28/06/2023 Stefan Anderson Since the beginning of the SARS-CoV-2 pandemic, the popular assumption was that people displaying severe symptons were also the most contagious. But new data from a controversial Imperial College London study published on Tuesday found the two participants that were the biggest “superspreaders” of the virus both displayed only minor symptoms. “How symptomatic a person […] Continue reading -> The Gambia Mandates Pre-shipment Quality Testing for All Medicines Exported from India 28/06/2023 Megha Kaveri The Gambia has mandated pre-shipment quality testing on all pharmaceutical products exported from India. The requirement will come into effect on 1 July 2023. It can be understood as an after-effect of last year’s scandal whereby India-manufactured cough syrups allegedly claimed the lives of 66 children in The Gambia in 2022 . Following the episode, […] Continue reading -> Medicines Patent Pool Announces Licenses for Generic COVID-19 Antiviral 27/06/2023 Stefan Anderson The Medicines Patent Pool (MPP) announced sublicensing agreements with seven manufacturers to produce and distribute generic versions of Japanese pharmaceutical company Shinogi’s COVID-19 antiviral treatment in 117 low- and middle-income countries. Ensitrelvir is an oral antiviral currently only approved in Japan under the country’s emergency regulatory approval system. The drug is being evaluated under a […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Virus ‘Superspreaders’: No Link to Severity of COVID-19 Symptoms 28/06/2023 Stefan Anderson Since the beginning of the SARS-CoV-2 pandemic, the popular assumption was that people displaying severe symptons were also the most contagious. But new data from a controversial Imperial College London study published on Tuesday found the two participants that were the biggest “superspreaders” of the virus both displayed only minor symptoms. “How symptomatic a person […] Continue reading -> The Gambia Mandates Pre-shipment Quality Testing for All Medicines Exported from India 28/06/2023 Megha Kaveri The Gambia has mandated pre-shipment quality testing on all pharmaceutical products exported from India. The requirement will come into effect on 1 July 2023. It can be understood as an after-effect of last year’s scandal whereby India-manufactured cough syrups allegedly claimed the lives of 66 children in The Gambia in 2022 . Following the episode, […] Continue reading -> Medicines Patent Pool Announces Licenses for Generic COVID-19 Antiviral 27/06/2023 Stefan Anderson The Medicines Patent Pool (MPP) announced sublicensing agreements with seven manufacturers to produce and distribute generic versions of Japanese pharmaceutical company Shinogi’s COVID-19 antiviral treatment in 117 low- and middle-income countries. Ensitrelvir is an oral antiviral currently only approved in Japan under the country’s emergency regulatory approval system. The drug is being evaluated under a […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
The Gambia Mandates Pre-shipment Quality Testing for All Medicines Exported from India 28/06/2023 Megha Kaveri The Gambia has mandated pre-shipment quality testing on all pharmaceutical products exported from India. The requirement will come into effect on 1 July 2023. It can be understood as an after-effect of last year’s scandal whereby India-manufactured cough syrups allegedly claimed the lives of 66 children in The Gambia in 2022 . Following the episode, […] Continue reading -> Medicines Patent Pool Announces Licenses for Generic COVID-19 Antiviral 27/06/2023 Stefan Anderson The Medicines Patent Pool (MPP) announced sublicensing agreements with seven manufacturers to produce and distribute generic versions of Japanese pharmaceutical company Shinogi’s COVID-19 antiviral treatment in 117 low- and middle-income countries. Ensitrelvir is an oral antiviral currently only approved in Japan under the country’s emergency regulatory approval system. The drug is being evaluated under a […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Medicines Patent Pool Announces Licenses for Generic COVID-19 Antiviral 27/06/2023 Stefan Anderson The Medicines Patent Pool (MPP) announced sublicensing agreements with seven manufacturers to produce and distribute generic versions of Japanese pharmaceutical company Shinogi’s COVID-19 antiviral treatment in 117 low- and middle-income countries. Ensitrelvir is an oral antiviral currently only approved in Japan under the country’s emergency regulatory approval system. The drug is being evaluated under a […] Continue reading -> Posts navigation Older postsNewer posts